Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Hummingbird Bioscience and Dartmouth's Geisel School of Medicine to Co-Host 3rd Annual Virtual VISTA Symposium on March 27, 2024 2024-03-13 17:00
Novel Molecules From Generative AI to Phase II: First Novel TNIK Inhibitors for Fibrotic Diseases Discovered and Designed Using Generative AI 2024-03-13 08:00
Metabolon and Cardiff University Centre for Neuropsychiatric Genetics and Genomics Forge Alliance to Propel Multiple Sclerosis Research 2024-03-12 20:05
Ajinomoto Bio-Pharma Services Garners Six 'CDMO Leadership Awards,' Further Establishing Its Industry Excellence 2024-03-12 20:00
Innovating the Future: ISoOR 2024 Annual Meeting Achieves Remarkable Success 2024-03-12 11:57
TFS HealthScience Unveils Asia Pacific Expansion, Elevating Patient Access and Innovation 2024-03-12 10:52
Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting 2024-03-12 08:00
SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada 2024-03-12 08:00
Appointment of Dr Darren Patti to Group Chief Operating Officer 2024-03-12 05:44
ImmunAbs Announces Conclusion of Phase 1 Clinical Trial, Revealing Positive Topline Results 2024-03-11 17:00
RemeGen Presents Oral Presentation on Evaluation of Its Proprietary Disitamab Vedotin (RC48) for Cervical Cancer at ESGO 2024 2024-03-11 10:36
Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024 2024-03-07 11:53
Luye Pharma's Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao 2024-03-07 10:11
Latest Updates of Viva Biotech's Portfolio Companies 2024-03-06 19:33
Laminar Pharmaceuticals S.A. receives recommendation from the Independent Data Monitoring Committee to advance to the next stage of CLINGLIO, the phase 2b/3 Clinical Trial of LAM561 in combination with RT and TMZ for adults with newly diagnosed glioblastoma 2024-03-06 08:45
Antengene to Present Four Preclinical Abstracts at AACR 2024, Highlighting Focus on Cancer Immunology, Targeted Agents and Novel Technology Platforms 2024-03-06 08:30
Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024 2024-03-06 05:30
Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production 2024-03-05 22:00
Angel Yeast Hosts Webinar with PPTI to Promote Sustainable Development of Proteins 2024-03-05 21:00
IRBM Expands Global Reach in Drug Discovery with New Boston Office 2024-03-05 20:24
1 4 5 6 7 8 210